CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 585 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00904150
NCT00904150N/ACompleted

A Case-control Study of the Molecular Genetics of Menstrual Migraine (Pure Menstrual and Menstrually-related Migraine)

The City of London Migraine Clinic·observational·Posted May 19, 2009·Updated Feb 24, 2014

In Brief

An observational study for Migraine. Completed, enrolled 585 participants across 1 site.

Detailed Summary

The investigators hypothesize that genes that play a role in menstrual migraine can be identified using a well characterised migraine population and a comprehensive genome-wide association scan approach. The aim of the study is to identify genes, genetic regions, and the effect of hormones on expression profiles in women with menstrual migraine compared to a control population with no personal or first-degree family history of migraine. In this case control study, saliva samples will be taken from 300 cases and 300 controls for DNA analysis. Blood samples from 30 cases and 30 controls will be taken during the follicular phase as well as the luteal phase of the menstrual cycle for ribonucleic acid (RNA) analysis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited Kingdom
CollaboratorsGriffith University

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 19, 2009
Enrollment StartNov 1, 2007
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 17.1 years ago